Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.20.2
Commitments and Contingencies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Aug. 03, 2020
Dec. 04, 2019
Jul. 25, 2019
Jun. 21, 2019
Apr. 02, 2019
Jan. 14, 2019
Aug. 17, 2016
Jun. 30, 2020
Jun. 30, 2020
Novotek Therapeutics Inc., and NovoTek Pharmaceuticals Limited [Member]                  
Loss contingency, damages sought, value       $ 1,551,562          
Neelima Varma and St.David's [Member]                  
Loss contingency, seeking description     On July 25, 2019, the Company was notified that on July 23, 2019, a complaint was filed by Neelima Varma, against the Company and St. David's Healthcare Partnership, L.P., LLP ("St. David's"), in the district court of Travis County, Texas, alleging, among other things, negligence, gross negligence and strict product liability, breach of express warranty, breach of implied warranty and fraudulent misrepresentation and omission, with respect to a medical device which the Company had sold through one its distributors to St. David's. Ms. Varma is seeking aggregate monetary relief from the Company and St. David's in excess of $1,000,000.            
St.David's [Member]                  
Loss contingency, seeking excess value     $ 1,000,000            
Advisory Board [Member]                  
Number of shares issued   $ 25,000              
Stock based compensation               $ 8,333 $ 50,000
Settlement Agreement [Member] | Watts Action [Member]                  
Payment of attorney' fees           $ 200,000      
Settlement Agreement [Member] | Watts and Chan Action [Member]                  
Payment of attorney' fees         $ 325,000        
Settlement Agreement [Member] | ChubeWorkx [Member]                  
Percentage of royalty received             5.00%    
Settlement Agreement and General Release [Member]                  
Number of shares issued $ 300,000                
Stock issued during the period 500,000                
Debt instrument, description On August 5, 2020, the Company (i) paid to ChubeWorkx an amount equal to $300,000 and (ii) delivered to ChubeWorkx 500,000 shares of the Company's common stock (the "Shares"). The Company granted ChubeWorkx registration rights with respect to the Shares. In the event that the Company fails to file a resale registration statement covering the Shares by August 18, 2020 (the "Filing Deadline"), or fails to cause such registration statement to be declared effective by the earlier of October 2, 2020 or 45 days after the filing of such registration statement (the "Effectiveness Deadline"), then, on each of the Filing Deadline and the Effectiveness Deadline, as the case may be, and on each monthly anniversary thereof (if the such registration statement shall not have been filed or declared effective by such date, as the case may be) until such registration statement is filed or declared effective, the Company shall pay to ChubeWorkx an amount in cash, as partial liquidated damages equal to 1.0% of the market value of the Shares.